Anti-interferon-β neutralising activity is not entirely mediated by antibodies-Reference-Cited by-同舟云学术

Anti-interferon-β neutralising activity is not entirely mediated by antibodies

Published:2007-12 Issue:1-2 Volume:192 Page:198-205
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Gilli Francesca,Marnetto Fabiana,Caldano Marzia,Valentino Paola,Granieri Letizia,Di Sapio Alessia,Capobianco Marco,Sala Arianna,Malucchi Simona,Kappos Ludwig,Lindberg Raija L.P.,Bertolotto Antonio

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference38 articles.

1. Further study on the specificity and incidence of neutralising antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b;Antonelli;J. Neurol. Sci.,1999

2. Interferonβ neutralising antibodies in multiple sclerosis: neutralising activity and cross-reactivity with three different preparations;Bertolotto;Immunopharmacology,2000

3. Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification;Bertolotto;J. Immunol. Methods,2001

4. Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patients;Bertolotto;Neurology,2003

5. Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies;Bertolotto;J. Neurol. Neurosurg. Psychiatry,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments;Neuroinflammation;2018

2. MxA mRNA decrease preceding NAb detection in IFNβ-treated MS patients;Brain and Behavior;2017-02-09

3. Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ;PLOS ONE;2017-01-12

4. The Impact of Methylprednisolone Pulses during Relapses of Multiple Sclerosis on the Kinetics of Anti-Interferon-Beta Antibodies;European Neurology;2016

5. Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing–remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up;Journal of Neuroimmunology;2015-10